Sung Wuk Kim

USPTO Granted Patents = 31 (Patent Applications = 19)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 15)

Average Co-Inventor Count = 7.7

ph-index = 7

Forward Citations = 114(Granted Patents)

Location History:

Daejon, KR (1994)
Seongnam, KR (2013)
Seongnam-si, KR (2011 - 2022)
Gyeonggi-do, KR (2011 - 2023)

Company Filing History:

16 out of 27

Hanall Biopharma Co., Ltd.

patents

13 out of 17

Immunomet Therapeutics Inc.

patents

3 out of 623

Korea Research Institute of Chemical Technology

patents

4. 1 out of 2

Hanall Pharmaceutical Company, Ltd.

patents

5. 1 out of 321

Korea Research Institute of Bioscience and Biotechnology

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12377061 - Composition for promoting hair growth comprising a guanine derivative (2025-08-05),

2. 11613578 - Antibody binding to FCRN for treating autoimmune diseases (2023-03-28),

3. 11572341 - Biguanide compound and use thereof (2023-02-07),

4. 11465989 - Guanidine compounds and use thereof (2022-10-11),

5. 10626085 - Biguanide compound and use thereof (2020-04-21),

6. 10590081 - Guanidine compounds and use thereof (2020-03-17),

7. 10544226 - Antibody binding to FcRn for treating autoimmune diseases (2020-01-28),

8. 10376480 - Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient (2019-08-13),

9. 10336825 - Antibody binding to FcRn for treating autoimmune diseases (2019-07-02),

10. 10280207 - FcRn-specific human antibody and composition for treatment of autoimmune diseases (2019-05-07),

11. 10058558 - Pharmaceutical composition comprising N1-cyclic amine-N5-substituted biguanide derivatives as an ingredient for preventing or treating fibrosis (2018-08-28),

12. 9993446 - Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient (2018-06-12),

13. 9580490 - Uses of modified human tumor necrosis factor receptor-1 polypeptide (2017-02-28),

14. 9540325 - N1-cyclic amine-N5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same (2017-01-10),

15. 9539238 - Pharmaceutical composition comprising a biguanide derivative as an active ingredient for preventing or treating glioblastoma (2017-01-10),

Title: Sung Wuk Kim: Pioneering Inventor from Gyeonggi-do, KR

Introduction: Sung Wuk Kim is a distinguished inventor hailing from Gyeonggi-do, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sung Wuk Kim holds several patents in the realm of electronics and telecommunications, showcasing his continuous dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Sung Wuk Kim has worked tirelessly to develop cutting-edge solutions that have revolutionized the industry. His innovative mindset and passion for creating have led to the successful implementation of numerous projects.

Collaborations: Sung Wuk Kim has collaborated with leading tech companies and research institutions worldwide, fostering a culture of innovation and knowledge-sharing. His ability to work in diverse teams has resulted in the development of pioneering technologies that have left a lasting impact.

Conclusion: Sung Wuk Kim's relentless pursuit of innovation and his commitment to excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors and serves as a testament to the power of creativity and perseverance in driving progress.

This text is generated by artificial intelligence and may not be accurate.